We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

627 hedge funds and large institutions have $10.4B invested in Charles River Laboratories in 2022 Q2 according to their latest regulatory filings, with 66 funds opening new positions, 263 increasing their positions, 218 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more call options, than puts

Call options by funds: $33M | Put options by funds: $27.2M

21% more repeat investments, than reductions

Existing positions increased: 263 | Existing positions reduced: 218

1.59% more ownership

Funds ownership: 94.28% → 95.87% (+1.6%)

3% less funds holding

Funds holding: 644 → 627 (-17)

11% less first-time investments, than exits

New positions opened: 66 | Existing positions closed: 74

23% less capital invested

Capital invested by funds: $13.5B → $10.4B (-$3.1B)

43% less funds holding in top 10

Funds holding in top 10: 7 → 4 (-3)

Holders
627
Holders Change
-17
Holders Change %
-2.64%
% of All Funds
10.56%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.07%
New
66
Increased
263
Reduced
218
Closed
74
Calls
$33M
Puts
$27.2M
Net Calls
+$5.79M
Net Calls Change
+$6.45M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$216M
2
Allspring Global Investments
Allspring Global Investments
North Carolina
+$149M
3
JSP
Jackson Square Partners
California
+$106M
4
SCA
Southpoint Capital Advisors
New York
+$97.7M
5
AI
Ariel Investments
Illinois
+$92.8M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$211M
2
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$68.9M
3
Millennium Management
Millennium Management
New York
-$56M
4
Citadel Advisors
Citadel Advisors
Florida
-$51M
5
Victory Capital Management
Victory Capital Management
Texas
-$25.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
FAF
226
Första AP-fonden
Sweden
$2.4M +$2.74M +11,200 New
Cerity Partners
227
Cerity Partners
New York
$2.37M -$2.85M -11,646 -51%
Nomura Asset Management
228
Nomura Asset Management
Japan
$2.36M +$17.3K +71 +0.6%
GKIM
229
GW&K Investment Management
Massachusetts
$2.32M -$121K -495 -4%
ACM
230
Argent Capital Management
Missouri
$2.32M -$32.7K -134 -1%
CIP
231
Capital Insight Partners
Arizona
$2.32M +$123K +503 +5%
SAM
232
Storebrand Asset Management
Norway
$2.27M -$99.5K -407 -4%
AI
233
Atria Investments
North Carolina
$2.21M -$70.1K -287 -3%
Lazard Asset Management
234
Lazard Asset Management
New York
$2.15M +$2.45M +10,047 +251,175%
HF
235
HRT Financial
New York
$2.12M +$2.42M +9,891 New
AAM
236
Azzad Asset Management
Virginia
$2.12M +$1.36M +5,583 +106%
X
237
Xponance
Pennsylvania
$2.09M +$370K +1,516 +18%
IG
238
ING Group
Netherlands
$2.05M +$380K +1,554 +19%
AAF
239
Andra AP-fonden
Sweden
$2.03M +$2.32M +9,500 New
CAM
240
ClariVest Asset Management
California
$1.95M -$562K -2,300 -20%
YCM
241
Yousif Capital Management
Michigan
$1.94M -$4.89K -20 -0.2%
Comerica Bank
242
Comerica Bank
Texas
$1.91M +$24.2K +99 +1%
Mawer Investment Management
243
Mawer Investment Management
Alberta, Canada
$1.91M +$721K +2,951 +49%
URS
244
Utah Retirement Systems
Utah
$1.9M – – –
TC
245
TownSquare Capital
Utah
$1.9M +$102K +416 +5%
JIM
246
Jensen Investment Management
Oregon
$1.85M +$2.12M +8,660 New
WTC
247
WhitTier Trust Company
Nevada
$1.83M +$147K +602 +8%
SEIA
248
Signature Estate & Investment Advisors
California
$1.82M +$453K +1,853 +28%
KAS
249
Kestra Advisory Services
Texas
$1.79M +$292K +1,194 +17%
GIBU
250
Gulf International Bank (UK)
United Kingdom
$1.78M – – –
8 9
10
11 12

CRL Hedge Fund Activity: Q2 2022 in Review

627 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2022, worth a combined $10.4B — down 23% from $13.5B a quarter earlier.

Sellers outnumbered buyers: 74 funds closed out of CRL and 66 opened new positions — a net loss of 8 holders — while 218 trimmed existing stakes and 263 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $216M. The largest seller was Fidelity Investments, cutting an estimated $211M.

  • 627 institutional investors held Charles River Laboratories (CRL) as of Q2 2022, down from 644 in Q1 2022.
  • Funds reported $10.4B of Charles River Laboratories stock for Q2 2022, down 23% quarter-over-quarter.
  • 66 funds opened new Charles River Laboratories positions in Q2 2022 and 74 closed out, a net change of -8 holders.
  • The largest Charles River Laboratories buyer in Q2 2022 was T. Rowe Price Associates, an estimated $216M added.
  • The largest Charles River Laboratories seller in Q2 2022 was Fidelity Investments, an estimated $211M sold.

Based on aggregated 13F filings for Q2 2022.